Welcome to our dedicated page for Owens & Minor news (Ticker: OMI), a resource for investors and traders seeking the latest updates and insights on Owens & Minor stock.
Owens & Minor, Inc. (NYSE: OMI) generates a steady flow of corporate, financial, and strategic news as it transitions into Accendra Health, Inc. and refocuses on home-based care. Company press releases and SEC filings describe a multi-step transformation that includes the sale of its Products & Healthcare Services (P&HS) segment, a shift toward a pure play home-based care platform centered on the Patient Direct business, and a corporate name and ticker change to Accendra Health, Inc. and ACH on the New York Stock Exchange.
News related to OMI has recently covered transaction announcements, such as the definitive agreement and subsequent completion of the sale of the P&HS segment to an affiliate of Platinum Equity, along with details of the retained equity stake and associated tax attributes. Earnings releases provide quarterly and year-to-date financial results for continuing operations, which primarily represent the Patient Direct segment and certain functional operations, and discuss management’s views on the company’s financial outlook and strategic priorities.
Investors and observers will also find corporate governance and leadership updates in the news flow, including executive appointments, role changes, and amendments to executive compensation and retirement plans that are connected to the company’s evolving structure. Additional items include announcements of participation in investor conferences, where management presents the company’s strategy and financial profile, and commercial agreements such as the national preferred DME network arrangement involving Apria and Byram with Optum Health.
This news page for OMI serves as a historical archive of Owens & Minor’s communications as it moves toward operating as Accendra Health, Inc. under the ACH ticker. Readers can use it to trace the company’s shift from a combination of hospital-focused distribution and home-based care toward a focused Patient Direct platform, as well as to follow key regulatory filings, transaction milestones, and strategic announcements.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Owens & Minor, Inc. (NYSE: OMI) will release its financial results for the first quarter of 2023 on May 5, 2023, before the market opens. A conference call for investors and analysts will take place at 8:30 a.m. ET the same day. The call can be accessed via toll-free and toll dial-in numbers. Stakeholders are encouraged to participate in the live webcast available on the company's investor relations page. Founded in 1882 and based in location value="LU/us.va.rchmnd"Richmond, Va., Owens & Minor is a Fortune 500 healthcare solutions company serving both hospitals and home healthcare sectors with an extensive range of products and proprietary technology.
Owens & Minor, Inc. (NYSE: OMI) announced its executive leadership will participate in a fireside chat at the Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference. The event is scheduled for Thursday, March 2, at 8:45 a.m. Eastern Time. Interested parties can access the live webcast via the company's investor relations page, with a replay available after the presentation. Owens & Minor, a Fortune 500 healthcare solutions provider, specializes in product manufacturing, delivery, and services for patients both in hospitals and at home. The company has been operating for over 140 years and employs more than 20,000 individuals globally.
Owens & Minor, Inc. (NYSE-OMI) reported impressive Q4 results with a 135% revenue increase in its Patient Direct segment, totaling $2.6 billion consolidated revenue. The operating cash flow stood at $325 million for 2022, up 162% year-over-year. However, challenges persist in the global products division, prompting an Operating Model Realignment Program expected to generate $30 million in adjusted operating income in 2023 and $200 million by 2025. The company anticipates 2023 revenue between $10.1 billion and $10.5 billion, with adjusted EBITDA projected at $490-$550 million.
Owens & Minor, Inc. (NYSE: OMI) is set to announce its financial results for the fourth quarter and full year of 2022 on February 28, 2023, before market opening. A conference call for investors and analysts will follow at 8:00 a.m. ET. Participants can join via a toll-free phone line or through a live webcast on the company’s investor relations page. Owens & Minor is a leading healthcare solutions provider with a focus on supply chain management, PPE manufacturing, and home health services. The company has been operational since 1882 and employs over 20,000 people globally.